
SelfDisrpt is a done-for-you LinkedIn ghostwriting and profile management service for founders and fund managers, covering content, outreach, and profile management. It offers a Content plan at $2,500/mo with an account manager, 5 weekly posts, outreach scripts and unlimited revisions, and a Done-For-You plan at $5,000/mo that adds posting, engagement, daily comments, cold outreach and inbox management.
Stop stacking subscriptions. Call every data provider - emails, phones, enrichment, intent - from Claude Code, billed by credits, on a single API key.
Free to start. No credit card required.
plus 40+ data providers in one Unified API accessible from your coding agent
We're working on creating a detailed video review for SelfDisrpt.
SelfDisrpt is recommended for founders and fund managers who want their LinkedIn content, outreach, and profile management done for them by operators, with plans ranging from content creation to fully managed posting, engagement, and inbox management.
Win Column offers two pricing tiers starting at $2,500 per month for content creation and outreach managed by a dedicated account manager with 5 weekly posts and unlimited revisions. The $5,000 per month Done-For-You plan includes everything in the Content Package plus daily comments, cold outreach, inbox management, and full account management. Both plans feature bi-weekly content interviews and 24/7 Slack support, with no trial mentioned.
Win Column is ready to use out of the box with no setup beyond sign-up. Simply choose your content package and provide basic information to start growing your LinkedIn profile immediately.
Win Column offers two pricing tiers starting at $2,500 per month for content creation and outreach managed by a dedicated account manager with 5 weekly posts and unlimited revisions. The $5,000 per month Done-For-You plan includes everything in the Content Package plus daily comments, cold outreach, inbox management, and full account management. Both plans feature bi-weekly content interviews and 24/7 Slack support, with no trial mentioned.